Search Results - "Zanger, Sandra"

CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake (123/131I-mIBG) in vitro and in vivo: a promising candidate for advancing theranostics in neuroendocrine tumors by Grand-Guillaume, Joana, Mansi, Rosalba, Gaonkar, Raghuvir H, Zanger, Sandra, Fani, Melpomeni, Eugster, Philippe J, Beck Popovic, Maja, Grouzmann, Eric, Abid, Karim

“…Background Neuroblastoma (NB) and pheochromocytoma/paraganglioma (PHEO/PGL) are neuroendocrine tumors. Imaging of these neoplasms is performed by scintigraphy…”
Get full text

SPECT Imaging of SST2-Expressing Tumors with 99mTc-Based Somatostatin Receptor Antagonists: The Role of Tetraamine, HYNIC, and Spacers by Gaonkar, Raghuvir Haridas, Wiesmann, Fabius, Del Pozzo, Luigi, McDougall, Lisa, Zanger, Sandra, Mikołajczak, Renata, Mansi, Rosalba, Fani, Melpomeni

“…[99mTc]Tc-HYNIC-TOC is the most widely used 99mTc-labeled somatostatin receptor (SST) agonist for the SPECT imaging of SST-expressing tumors, such as…”
Get full text

61 Cu-PSMA-Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging by Basaco Bernabeu, Tais, Mansi, Rosalba, Del Pozzo, Luigi, Zanger, Sandra, Gaonkar, Raghuvir H, McDougall, Lisa, De Rose, Francesco, Jaafar-Thiel, Leila, Herz, Michael, Eiber, Matthias, Ulaner, Gary A, Weber, Wolfgang A, Fani, Melpomeni

“…The demand for PET tracers that target prostate-specific membrane antigen (PSMA) continues to increase. Meeting this demand with approved Ga- and F-labeled…”
Get full text

61Cu-PSMA–Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging by Bernabeu, Tais Basaco, Mansi, Rosalba, Del Pozzo, Luigi, Zanger, Sandra, Gaonkar, Raghuvir H, McDougall, Lisa, De Rose, Francesco, Jaafar-Thiel, Leila, Herz, Michael, Eiber, Matthias, Ulaner, Gary A, Weber, Wolfgang A, Fani, Melpomeni

“…The demand for PET tracers that target prostate-specific membrane antigen (PSMA) continues to increase. Meeting this demand with approved 68Ga- and 18F-labeled…”
Get full text

SPECT Imaging of SST2-Expressing Tumors with 99m Tc-Based Somatostatin Receptor Antagonists: The Role of Tetraamine, HYNIC, and Spacers by Gaonkar, Raghuvir Haridas, Wiesmann, Fabius, Del Pozzo, Luigi, McDougall, Lisa, Zanger, Sandra, Mikołajczak, Renata, Mansi, Rosalba, Fani, Melpomeni

“…[ Tc]Tc-HYNIC-TOC is the most widely used Tc-labeled somatostatin receptor (SST) agonist for the SPECT imaging of SST-expressing tumors, such as neuroendocrine…”
Get full text